James W. Carroll
Director · Office of National Drug Control Policy
Transactions1Bought0Sold1
Amounts are the ranges the disclosure form asks for, not exact figures. The form does not ask for a precise number, so we do not show one.
Disclosed transactions
| Date | Asset | Type | Amount | Account |
|---|---|---|---|---|
| Jan 12, 2021 | BlackRock LifePath Index 2020 | sale | $15,001 - $50,000 | — |
Filings on record
Every disclosure OGE lists for James W. Carroll, including the ones we have not read. A filing with no figures is not an absence of trading.
| Filed | Type | Trades read | Status | Source |
|---|---|---|---|---|
| Feb 2, 2021 | Termination | 1 | Read | filing |
| May 4, 2018 | Ethics Agreement | — | Periodic report, published as a scan we do not read | filing |
2 filings listed · 1 not read · source oge.gov
This is public record, presented as public record. It is not a trading signal and not investment advice.
Get the alerts